Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05472545

Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
Oklahoma State University Center for Health Sciences · Academic / Other
Sex
Female
Age
14 Years
Healthy volunteers
Accepted

Summary

This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.

Detailed description

Adolescents with a family history of adverse childhood experiences (ACEs) are at heightened risk for depression and other mental health problems related to poor emotion regulation (ER). The proposed study will test the efficacy of a real-time fMRI dyadic neurofeedback (DNF) protocol to promote healthy ER-related neurodevelopment in female adolescents with a maternal history of ACEs. The proposed study will use DNF to provide neurofeedback from the adolescent's anterior insular cortex (aIC) to the adolescent's mother as the mother and adolescent engage in an emotion discussion task together. Parents and adolescents (n=35 active DNF; n=35 control) will communicate via microphones and noise-canceling headphones while the adolescent is undergoing fMRI scanning. Specific aims of the current study are to determine: 1) the effects of aIC DNF on the developing ER network in adolescents with a history of maternal ACEs, 2) associations between parenting practices during DNF and reduced adolescent aIC activation, and 3) longitudinal effects of aIC DNF on adolescent internalizing symptoms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeurofeedbackReal-time functional magnetic resonance imaging dyadic neurofeedback

Timeline

Start date
2023-03-13
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2022-07-25
Last updated
2025-08-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05472545. Inclusion in this directory is not an endorsement.